20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          Bunyaviruses are emerging zoonotic pathogens of public-health concern. Lack of structures for proteins on the viral membrane (“envelope”) surface limits understanding of entry. We describe atomic-level structures for the globular “head” of the envelope protein, glycoprotein N (Gn), from two members, severe fever with thrombocytopenia syndrome virus (SFTSV) and Rift Valley fever virus (RVFV), of Phleboviruses genus in the bunyavirus family, and a structure of the SFTSV Gn bound with a neutralizing antibody Fab. The results show the folded Gn structure and define virus-specific neutralizing-antibody binding sites. Biochemical assays suggest that dimerization, mediated by conserved cysteines in the region (“stem”) connecting the Gn head with the transmembrane domain, is a general feature of bunyavirus envelope proteins and that the dimer is probably the olimeric form on the viral surface.

          Abstract

          Severe fever with thrombocytopenia syndrome virus (SFTSV) and Rift Valley fever virus (RVFV) are two arthropod-borne phleboviruses in the Bunyaviridae family, which cause severe illness in humans and animals. Glycoprotein N (Gn) is one of the envelope proteins on the virus surface and is a major antigenic component. Despite its importance for virus entry and fusion, the molecular features of the phleboviruse Gn were unknown. Here, we present the crystal structures of the Gn head domain from both SFTSV and RVFV, which display a similar compact triangular shape overall, while the three subdomains (domains I, II, and III) making up the Gn head display different arrangements. Ten cysteines in the Gn stem region are conserved among phleboviruses, four of which are responsible for Gn dimerization, as revealed in this study, and they are highly conserved for all members in Bunyaviridae. Therefore, we propose an anchoring mode on the viral surface. The complex structure of the SFTSV Gn head and human neutralizing antibody MAb 4–5 reveals that helices α6 in subdomain III is the key component for neutralization. Importantly, the structure indicates that domain III is an ideal region recognized by specific neutralizing antibodies, while domain II is probably recognized by broadly neutralizing antibodies. Collectively, Gn is a desirable vaccine target, and our data provide a molecular basis for the rational design of vaccines against the diseases caused by phleboviruses and a model for bunyavirus Gn embedding on the viral surface.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Epitopes involved in antibody-mediated protection from Ebola virus.

          To determine the ability of antibodies to provide protection from Ebola viruses, monoclonal antibodies (mAbs) to the Ebola glycoprotein were generated and evaluated for efficacy. We identified several protective mAbs directed toward five unique epitopes on Ebola glycoprotein. One of the epitopes is conserved among all Ebola viruses that are known to be pathogenic for humans. Some protective mAbs were also effective therapeutically when administered to mice 2 days after exposure to lethal Ebola virus. The identification of protective mAbs has important implications for developing vaccines and therapies for Ebola virus.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM.

            Measles virus, a major cause of childhood morbidity and mortality worldwide, predominantly infects immune cells using signaling lymphocyte activation molecule (SLAM) as a cellular receptor. Here we present crystal structures of measles virus hemagglutinin (MV-H), the receptor-binding glycoprotein, in complex with SLAM. The MV-H head domain binds to a β-sheet of the membrane-distal ectodomain of SLAM using the side of its β-propeller fold. This is distinct from attachment proteins of other paramyxoviruses that bind receptors using the top of their β-propeller. The structure provides templates for antiviral drug design, an explanation for the effectiveness of the measles virus vaccine, and a model of the homophilic SLAM-SLAM interaction involved in immune modulations. Notably, the crystal structures obtained show two forms of the MV-H-SLAM tetrameric assembly (dimer of dimers), which may have implications for the mechanism of fusion triggering.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Structural characterization of the 1918 influenza virus H1N1 neuraminidase.

              Influenza virus neuraminidase (NA) plays a crucial role in facilitating the spread of newly synthesized virus in the host and is an important target for controlling disease progression. The NA crystal structure from the 1918 "Spanish flu" (A/Brevig Mission/1/18 H1N1) and that of its complex with zanamivir (Relenza) at 1.65-A and 1.45-A resolutions, respectively, corroborated the successful expression of correctly folded NA tetramers in a baculovirus expression system. An additional cavity adjacent to the substrate-binding site is observed in N1, compared to N2 and N9 NAs, including H5N1. This cavity arises from an open conformation of the 150 loop (Gly147 to Asp151) and appears to be conserved among group 1 NAs (N1, N4, N5, and N8). It closes upon zanamivir binding. Three calcium sites were identified, including a novel site that may be conserved in N1 and N4. Thus, these high-resolution structures, combined with our recombinant expression system, provide new opportunities to augment the limited arsenal of therapeutics against influenza.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                5 September 2017
                21 August 2017
                : 114
                : 36
                : E7564-E7573
                Affiliations
                [1] aChinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences , Beijing 100101, China;
                [2] bShenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People’s Hospital , Shenzhen 518112, China;
                [3] c State Key Laboratory of Agrobiotechnology , Beijing 100193, China;
                [4] dDepartment of Microbiology and Immunology, College of Biological Sciences, China Agricultural University , Beijing 100193, China;
                [5] eInstitute of Genetics and Developmental Biology, Chinese Academy of Sciences , Beijing 100101, China;
                [6] fInstitute of Pathogenic Microbiology, Jiangsu Provincial Center for Disease Prevention and Control , Key Laboratory of Enteric Pathogenic Microbiology, Ministry Health, Nanjing 210009, China;
                [7] gCenter for Influenza Research and Early-Warning, Chinese Academy of Sciences , Beijing 100101, China;
                [8] h National Institute of Biological Sciences , Beijing 102206, China;
                [9] iNational Center for Protein Science Shanghai, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201210, China;
                [10] jNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention , Beijing 102206, China;
                [11] kResearch Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences , Beijing 100101, China
                Author notes
                2To whom correspondence may be addressed. Email: gaofeng@ 123456genetics.ac.cn or gaof@ 123456im.ac.cn .

                Edited by Stephen C. Harrison, Children’s Hospital Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, and approved July 25, 2017 (received for review March 30, 2017)

                Author contributions: Y.W. and G.F.G. designed research; Y.W., Y. Zhu, F.G., B.O.O., Y.B., S.L., C.Z., G.H., Y. Zhang, Y.L., and J.Q. performed research; Y.J., W.F., M.L., and R.Z. contributed new reagents/analytic tools; Y.W., F.G., Y.C., S.L., M.D., N.L., Y.S., and G.F.G. analyzed data; and Y.W., F.G., G.W., and G.F.G. wrote the paper.

                1Y.W., Y. Zhu, F.G., and Y.J. contributed equally to this work.

                Author information
                http://orcid.org/0000-0002-3284-8781
                http://orcid.org/0000-0002-3869-615X
                Article
                PMC5594662 PMC5594662 5594662 201705176
                10.1073/pnas.1705176114
                5594662
                28827346
                56f40151-62d2-4bdf-b6ea-46e5c7e39e9e
                History
                Page count
                Pages: 10
                Funding
                Funded by: Youth Innovation Promotion Association of the Chinese Academy of Sciences (Youth Innovation Promotion Association CAS) 501100004739
                Award ID: 2016086
                Funded by: National Natural Science Foundation of China (NSFC) 501100001809
                Award ID: 81330082
                Funded by: National Natural Science Foundation of China (NSFC) 501100001809
                Award ID: 81301465
                Funded by: China National Grand S&T Special Project
                Award ID: 2016ZX10004222-008
                Funded by: Strategic Priority Research Program of the Chinese Academy of Sciences
                Award ID: XDB08020100
                Funded by: Strategic Priority Research Program of the Chinese Academy of Sciences
                Award ID: XDPB03
                Funded by: National Natural Science Foundation of China (NSFC) 501100001809
                Award ID: 81621091
                Categories
                PNAS Plus
                Biological Sciences
                Microbiology
                PNAS Plus

                bunyavirus,SFTSV,glycoprotein,neutralizing antibody,RVFV
                bunyavirus, SFTSV, glycoprotein, neutralizing antibody, RVFV

                Comments

                Comment on this article